<?xml version="1.0" ?> <rss xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="2.0"><channel><title>Pharmaceutical Processing - News</title><link>http://www.pharmpro.com/rss.aspx?id=90</link><description>News</description><item><title>Antibiotic linked with rare but deadly heart risk</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/antibiotic-linked-with-rare-but-deadly-heart-risk/</link><description>
&lt;p&gt; An antibiotic widely used for bronchitis and other common infections seems to increase chances for sudden deadly heart problems, a rare but surprising risk found in a 14-year study.Zithromax, or azithromycin, is more expensive than other antibiotics, but it's popular because it often can be...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 21:17:41 GMT</pubDate></item><item><title>WHO and PAHO honor efforts to counter the actions of the tobacco industry in the Americas</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-pan-american-health-organization-who-and-paho-honor-efforts-to-counter-the-actions-/</link><description>
In observance of World No Tobacco Day, May 31, the World Health Organization...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 20:21:35 GMT</pubDate></item><item><title>NIH-funded research provides new clues on how ApoE4 affects Alzheimer&amp;#39;s risk</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-national-institutes-of-health-(nih)-nih-funded-research-provides-new-clues-on-how-apoe/</link><description>
Common variants of the ApoE gene are strongly associated with the risk of developing late-onset Alzheimer's disease, but the gene's role in the disease has been unclear.  Now, researchers funded by the National Institutes of Health have found that in mice, having the most risky variant of...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 18:21:30 GMT</pubDate></item><item><title>Paralyzed individuals use thought-controlled robotic arm to reach and grasp</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-national-institutes-of-health-(nih)-paralyzed-individuals-use-thought-controlled-robot/</link><description>
In an ongoing clinical trial, a paralyzed woman was able to reach for and sip from a drink on her own -- for the first time in nearly 15 years -- by using her thoughts to direct a robotic arm.  The trial, funded in part by the National Institutes of Health, is evaluating the safety and...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 18:21:22 GMT</pubDate></item><item><title>Fette Compacting Opens Competence Center for Tableting Technology</title><link>http://www.pharmpro.com/News/2012/05/Supplier-News-Fette-Compacting-Opens-Competence-Center-for-Tableting-Technology/</link><description>
&lt;p&gt;This April, FETTE COMPACTING, a subsidiary of the LMT Group, opened a competence center for tableting technology in Brazil. Based in Campinas, not far from São Paulo. &lt;/p&gt;
</description>Jonnatha Mayberry<pubDate>Wed, 16 May 2012 17:05:06 GMT</pubDate></item><item><title>Former McDonald&amp;#39;s exec joins Dunkin&amp;#39; Brands board</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/former-mcdonalds-exec-joins-dunkin-brands-board/</link><description>
&lt;p&gt; Dunkin' Brands Group Inc. has named a former McDonald's Corp. executive to its board of directors.The parent company of Dunkin' Donuts and Baskin-Robbins said Wednesday that Raul Alvarez is joining its board. Alvarez, 56, previously served as McDonald's president and chief operating officer. He...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 16:17:10 GMT</pubDate></item><item><title>GlaxoSmithKline closes on Theravance deal</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/glaxosmithkline-closes-on-theravance-deal/</link><description>
&lt;p&gt; British drug maker GlaxoSmithKline PLC has closed on a deal that boosts its interest in biotechnology company Theravance Inc. by 10 million shares.Theravance's shareholders approved the transaction on Tuesday.Last month GlaxoSmithKline said that it would buy the 10 million shares at $21.29...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 15:17:27 GMT</pubDate></item><item><title>Protesters disrupt WellPoint annual meeting</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/protesters-disrupt-wellpoint-annual-meeting/</link><description>
&lt;p&gt; WellPoint Inc. shareholders rejected a call for more disclosure about the health insurer's political contributions Wednesday during a shout-filled, contentious annual meeting.Union representatives and other protesters repeatedly interrupted Chairwoman and CEO Angela Braly after she opened the...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 15:17:20 GMT</pubDate></item><item><title>Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A</title><link>http://www.pharmpro.com/News/Feeds/2012/05/pharmaceutical-companies-baxter-baxter-announces-advate-approval-in-china-for-the-/</link><description>
DEERFIELD, Ill, May 16, 2012- Baxter International Inc. (NYSE:BAX) today announced&amp;#160; the approval of ADVATE [Recombinant Human Coagulation Factor VIII for injection] for the control and prophylaxis of bleeding episodes in individuals with hemophilia A (congenital factor VIII...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 13:21:36 GMT</pubDate></item><item><title>Panel Backs First Rapid, Take Home HIV Test</title><link>http://www.pharmpro.com/news/2012/05/agencies-and-organizations-Panel-Backs-First-Rapid-Take-Home-HIV-Test/</link><description>
&lt;p&gt;WASHINGTON (AP) — American consumers may soon be able to test themselves for the virus that causes AIDS in the privacy of their own homes, after a panel of experts on Tuesday recommended approval of the first rapid, over-the-counter HIV test.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 12:47:03 GMT</pubDate></item><item><title>Avalanche Biotechnologies and Lonza Announce Global Manufacturing Collaboration</title><link>http://www.pharmpro.com/news/2012/05/business-Avalanche-Biotechnologies-and-Lonza-Announce-Global-Manufacturing-Collaboration/</link><description>
&lt;p&gt;Avalanche Biotechnologies, Inc. and Lonza today announced a manufacturing collaboration focused on process development and scale-up efforts for the manufacturing of adeno-associated viral (AAV) vectors for gene therapy.&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 12:22:22 GMT</pubDate></item><item><title>Intuitive Bio Acquires Assets of Gentel Biosciences</title><link>http://www.pharmpro.com/news/2012/05/business-Intuitive-Bio-Acquires-Assets-of-Gentel-Biosciences/</link><description>
&lt;p&gt;Intuitive Biosciences, Inc. is pleased to announce its agreement to acquire the animal health and research tools assets and businesses of Gentel Biosciences. Intuitive is focused on serological tests for animal health and research and testing tools for the pharmaceutical, CRO, and academic research markets. &lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 12:15:48 GMT</pubDate></item><item><title>Scientists Hunt Ways to Stall Alzheimer&amp;#39;s Earlier</title><link>http://www.pharmpro.com/news/2012/05/newsletter-Scientists-Hunt-Ways-to-Stall-Alzheimers-Earlier/</link><description>
&lt;p&gt;WASHINGTON (AP) — Look for a fundamental shift in how scientists hunt ways to ward off the devastation of Alzheimer's disease — by testing possible therapies in people who don't yet show many symptoms, before too much of the brain is destroyed.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 12:08:45 GMT</pubDate></item><item><title>Arena Pharma Says it Plans New Stock Offering</title><link>http://www.pharmpro.com/news/2012/05/business-Arena-Pharma-Says-it-Plans-New-Stock-Offering/</link><description>
&lt;p&gt;SAN DIEGO (AP) — Arena Pharmaceuticals Inc. said Tuesday it plans to raise money by selling common stock in a public offering.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Wed, 16 May 2012 11:58:50 GMT</pubDate></item><item><title>India&amp;#39;s Piramal to buy US healthcare company</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/indias-piramal-to-buy-us-healthcare-company/</link><description>
&lt;p&gt; India's Piramal Healthcare said Wednesday it will buy Decision Resources Group, a U.S. healthcare information company, for 34 billion rupees ($635 million), as it slowly taps its cashpile for overseas acquisitions.Piramal's cautious deployment of $3.8 billion from the sale of its mainstay...
</description>Internal Administrator<pubDate>Wed, 16 May 2012 11:17:30 GMT</pubDate></item><item><title>Activist firm takes $600 million stake in PepsiCo</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/activist-firm-takes-600-million-stake-in-pepsico/</link><description>
&lt;p&gt; Activist investor Ralph Whitworth said Tuesday that his firm has taken a $600 million stake in PepsiCo Inc., a move that could ramp up pressure on the company to make changes.PepsiCo has faced investor dissatisfaction in recent years over its underperforming stock price and loss of market share...
</description>Internal Administrator<pubDate>Tue, 15 May 2012 21:17:31 GMT</pubDate></item><item><title>Avon finally calling, but Coty slams the door</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/avon-finally-calling-but-coty-slams-the-door/</link><description>
&lt;p&gt; Shares of Avon Products Inc. almost 11 percent Tuesday after the smaller beauty products maker Coty Inc. dropped its $10.7 billion takeover bid.Privately held Coty first made an offer for Avon Products public on April 2, and the relationship was contentious from the start. Avon said that offer...
</description>Internal Administrator<pubDate>Tue, 15 May 2012 20:17:14 GMT</pubDate></item><item><title>Bristol-Myers says FDA clears Mass. plant</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/bristol-myers-says-fda-clears-mass-plant/</link><description>
&lt;p&gt; Bristol-Myers Squibb Co. said Tuesday the Food and Drug Administration approved a new manufacturing plant where the company will produce its rheumatoid arthritis drug Orencia.The plant is in Devens, Mass. Bristol-Myers said about 300 scientists, engineers, quality specialists and other...
</description>Internal Administrator<pubDate>Tue, 15 May 2012 18:17:30 GMT</pubDate></item><item><title>Walgreen Adds 300 Drugs to its Value-Priced Generics Category</title><link>http://www.pharmpro.com/news/2012/05/business-Walgreen-Adds-300-Drugs-to-its-Value-Priced-Generics-Category/</link><description>
&lt;p&gt;DEERFIELD, Ill. (AP) — Drugstore chain Walgreen Co. is beefing up its Prescription Savings Club program for customers by expanding the discounts it offers on generic drugs, vaccines and other items.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 17:04:32 GMT</pubDate></item><item><title>Achillion Gets FDA Incentives for Hepatitis C Drug</title><link>http://www.pharmpro.com/news/2012/05/agencies-and-organizations-Achillion-Gets-FDA-Incentives-for-Hepatitis-C-Drug/</link><description>
&lt;p&gt;NEW HAVEN, Conn. (AP) — Achillion Pharmaceuticals Inc. said Tuesday it will receive incentives from regulators as it studies a new experimental treatment for the hepatitis C virus.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 16:56:00 GMT</pubDate></item><item><title>Health Canada Advises Caution When Selling or Buying Products at Garage Sales</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-health-canada-health-canada-advises-caution-when-selling-or-buyi/</link><description>
Health Canada is reminding you to put safety ahead of savings and to use caution when buying or selling items at garage sales or second-hand stores, particularly if they are intended for use by children.
</description>Internal Administrator<pubDate>Tue, 15 May 2012 15:21:20 GMT</pubDate></item><item><title>FTC Approves Final Settlement with CVS Caremark</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-ftc-ftc-approves-final-settlement-with-cvs-caremark/</link><description>
Following a public comment period, the FTC has accepted as final an order with CVS Caremark settling charges that it misrepresented the prices of certain Medicare Part D prescription drugs, including drugs used to treat breast cancer symptoms and epilepsy, at CVS and Walgreens pharmacies.
</description>Internal Administrator<pubDate>Tue, 15 May 2012 15:21:09 GMT</pubDate></item><item><title>FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA®</title><link>http://www.pharmpro.com/news/2012/05/agencies-and-organizations-FDA-Approves-Bristol-Myers-Squibb-Devens-Biologics-Manufacturing-Facility/</link><description>
&lt;p&gt;&lt;span&gt;Bristol-Myers Squibb Company announced today that the FDA has approved the company’s biologics manufacturing facility in Devens, Massachusetts for commercial production of ORENCIA&amp;#174; (abatacept). &lt;/span&gt;&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 15:11:41 GMT</pubDate></item><item><title>Countries of the Americas promote integrated action to eliminate neglected diseases</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-pan-american-health-organization-countries-of-the-americas-promote-integrated-actio/</link><description>
More than 100 million people in the Americas suffer from neglected infectious diseases, which...
</description>Internal Administrator<pubDate>Tue, 15 May 2012 14:21:23 GMT</pubDate></item><item><title>Cowher joins campaign to educate about melanoma</title><link>http://www.pharmpro.com/News/FeedsAP/2012/05/cowher-joins-campaign-to-educate-about-melanoma/</link><description>
&lt;p&gt; Bill Cowher wants to teach men about melanoma, a disease whose ravages he knows all too well.The Super Bowl-winning coach's wife died of the form of skin cancer in 2010. Now Cowher is the spokesman for a campaign called "Melanoma Exposed." Launched Tuesday, it seeks to educate all Americans —...
</description>Internal Administrator<pubDate>Tue, 15 May 2012 14:17:12 GMT</pubDate></item><item><title>NINR welcomes five new members to the National Advisory Council for Nursing Research</title><link>http://www.pharmpro.com/News/Feeds/2012/05/agencies-and-organizations-national-institutes-of-health-(nih)-ninr-welcomes-five-new-members-to-the-national-adv/</link><description>
The National Institute of Nursing Research (NINR) announces five new members to the National Advisory Council for Nursing Research (NACNR), the institute's principal advisory board. Members of the council are drawn from the scientific and lay communities, embodying a diverse perspective...
</description>Internal Administrator<pubDate>Tue, 15 May 2012 13:21:20 GMT</pubDate></item><item><title>Cardinal Health Brings Resolution to Litigation with DEA Settlement</title><link>http://www.pharmpro.com/news/2012/05/agencies-and-organizations-Cardinal-Health-Brings-Resolution-to-Litigation-with-DEA-Settlement/</link><description>
&lt;p&gt;Cardinal Health today said it had agreed to a settlement with the Drug Enforcement Agency (DEA) that allows the company to bring resolution to ongoing litigation. &lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 12:35:24 GMT</pubDate></item><item><title>Servier Lawyers Argue Diabetes-Diet Drug Scandal Trial Should Be Halted</title><link>http://www.pharmpro.com/news/2012/05/pharmaceutical-companies-Servier-Lawyers-Argue-Diabetes-Diet-Drug-Scandal-Trial-Should-Be-Halted/</link><description>
&lt;p&gt;NANTERRE, France (AP) — Lawyers for a French pharmaceutical group suspected in the deaths of at least 500 people argued Monday that a trial against their client should be halted as two separate cases should be rolled into one before the court can proceed.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 12:14:57 GMT</pubDate></item><item><title>Hospira Recalling One Lot of Pain Injections</title><link>http://www.pharmpro.com/news/2012/05/agencies-and-organizations-Hospira-Recalling-One-Lot-of-Pain-Injections/</link><description>
&lt;p&gt;WASHINGTON (AP) — Federal regulators are warning doctors in an online posting that one lot of injectable painkillers from Hospira may contain too much of the drug&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 12:10:40 GMT</pubDate></item><item><title>Clock Ticking With New Plan to Fight Alzheimer&amp;#39;s</title><link>http://www.pharmpro.com/news/2012/05/government-and-regulatory-Clock-Ticking-With-New-Plan-to-Fight-Alzheimers/</link><description>
&lt;p&gt;WASHINGTON (AP) — The clock is ticking: The first National Alzheimer's Plan sets a deadline of 2025 to finally find effective ways to treat, or at least stall, the mind-destroying disease.&lt;/p&gt;
&lt;p&gt;&lt;/p&gt;
</description>Mike Auerbach<pubDate>Tue, 15 May 2012 12:03:18 GMT</pubDate></item></channel></rss>
